Idagor 5/1,25/5 mg; 5/1,25/10 mg; 10/2,5/5 mg; 10/2,5/10 mg FC tablets
PDF Leaflet Revision Date: 12 April 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Substitution therapy for essential hypertension in adults controlled with amlodipine and perindopril/indapamide.
Dosage (summary)
One tablet daily, preferably in the morning before a meal.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated during pregnancy and lactation.
Key Drug Interactions
- Aliskiren
- Potassium-sparing diuretics
- Lithium
- Fluoroquinolones
Contraindications
- Hypersensitivity to ingredients
- History of angioedema
- Severe renal impairment
- Moderate to severe hepatic impairment
- Bilateral renal artery stenosis
Common side effects
- Hypokalaemia
- Dizziness
- Headache
- Cough
- Fatigue
Counselling Points
- Take in the morning before meals.
- Monitor blood pressure regularly.
- Report any signs of swelling or difficulty breathing.
Serious warnings
- Risk of hypotension
- Angioedema
- Renal impairment monitoring required
Important Disclaimer
The Idagor 5/1,25/5 mg; 5/1,25/10 mg; 10/2,5/5 mg; 10/2,5/10 mg FC tablets professional information leaflet below is the property of Servier Laboratories Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
